arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 9/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Nalmefene (SELINCRO) in alcohol dependence

    Peginterferon beta-1a (PLEGRIDY) for multiple sclerosis

    THERAPY FROM A CRITICAL VIEWPOINT

    Paracetamol (BEN-U-RON, generics) - no proven benefit for low back pain

    Adjuvant tamoxifen (NOLVADEX, generics) in breast cancer - guidelines recommend treatment duration of 10 years

    a-t READER'S QUESTIONS AND COMMENTS

    Hyponatremia with diuretics

    BEWARE! MISSINFORMATION

    MOSQUITO MED Läuseshampoo 10 against head lice

    CURRENT ADR NETWORK REPORT

    Lipodystrophia with multiple sclerosis drug glatiramer acetate (COPAXONE)

    SIDE EFFECTS

    Loss of fingerprint with cancer drugs
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles